Lake forest health and fitness: Bevacizumab Significantly Improves Survival for Patients with Recurrent and Metastatic Cervical Cancer

Friday, 8 February 2013

Bevacizumab Significantly Improves Survival for Patients with Recurrent and Metastatic Cervical Cancer

Source: National Cancer Institute - From the National Institutes of Health

From the National Institutes of Health

Related MedlinePlus Page: Cervical Cancer via MedlinePlus Health News Read More Here..

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)